Navigation Links
Genetic Data May Not Boost Heart Disease Predictions
Date:1/19/2009

Traditional risk factors are just as reliable, researchers say,,,,

MONDAY, Jan. 19 (HealthDay News) -- Although a particular genetic variation is associated with an increased risk for heart disease, knowing about it does not help doctors predict who is likely to get heart disease any more than using traditional risk factors, a new study finds.

There has been continuing excitement in recent years about the power of gene variations in predicting the risk for disease. However, in this case, knowing a variation increases the risk of cardiovascular trouble did not add more valuable information than could be gleaned from other risk factors, such as high blood pressure, high cholesterol and family history.

"Gene patterns are associated with an increased risk of heart disease, and the higher risk patterns are common," said lead researcher Nina P. Paynter, an instructor in medicine at Brigham and Women's Hospital in Boston and Harvard Medical School.

"However, it was not known if knowledge of a person's pattern, when added to knowledge of traditional risk factors including family history of heart disease, would improve the ability to predict levels of future heart disease risk for that person and possibly help with treatment decisions," she said.

The report is published in the Jan. 20 issue of the Annals of Internal Medicine.

For the study, Paynter's team collected data on 22,129 women who participated in the Women's Genome Health Study. At the start of the study, the women were free from any major chronic diseases.

Over 10.2 years of follow-up, the researchers found that adding information about gene patterns at a specific section of the genome, namely chromosome 9p21.3, did not meaningfully improve the ability to predict heart disease, compared with the use of traditional risk factors.

"This study only included white women, so it is not known if the results are applicable to women of different backgrounds or to men," Paynter noted.

Dr. Harlan M. Krumholz, a professor of cardiology at Yale University School of Medicine, put it this way: "It's an important study that should give us pause that information about whether our DNA will trump what we know from established risk factors. The genetic work is important in efforts to find targets for future therapies, but addressing modifiable risk factors is where we need to direct our attention."

However, Dr. Byron Lee, an assistant professor of cardiology at the University of California, San Francisco, noted that "while in this study, DNA testing did not improve our ability to predict cardiovascular disease, which is based on traditional risk factors like smoking and hypertension, there are literally millions of other specific genetic tests to look at."

"I expect DNA testing to become a standard part of risk assessment in the near future," Lee said.

More information

For more information on heart disease, visit the American Heart Association .



SOURCES: Nina P. Paynter, Ph.D., instructor in medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; Byron Lee, M.D., assistant professor, cardiology, University of California, San Francisco; Harlan M. Krumholz, M.D., professor of cardiology, Yale University School of Medicine, New Haven, Conn.; Jan. 20, 2009, Annals of Internal Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Genetic Data May Predict Colon Cancer Odds
2. FDA Issues Final Regulations for Genetically Engineered Animals
3. UT leads $2.5 million training program in pioneering area of genetic research
4. Identification of genetic markers for ulcerative colitis could lead to treatment
5. CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte Closes
6. Beta Release of a New Genetics Website- ItRunsInMyFamily.com
7. New Genetic Analysis Might Boost Breast Cancer Care
8. Genetic Variants Tied to Obesity
9. Genetic Link Between Type 1 Diabetes, Celiac Disease Seen
10. Genetic Markers Identified for Alcohol Response in UCSF Gallo Study
11. PTSD Risk Rooted in Stress and Genetics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Data May Not Boost Heart Disease Predictions 
(Date:3/22/2017)... Angeles, CA (PRWEB) , ... March 22, 2017 ... ... information community, announces the publication of the first issue of its companion print ... educate the public about cosmetic surgery thanks to information provided by board-certified doctors ...
(Date:3/22/2017)... San Francisco, CA (PRWEB) , ... March 22, ... ... headquartered in the California Bay Area providing insurance assistance, financial planning, and related ... conjunction with Endangered Species International to promote awareness of threatened species and wild ...
(Date:3/22/2017)... ... March 22, 2017 , ... The American Society ... authorization (PA) form for prescribers to improve patients’ access to the revolutionary therapy ... published as part of the article entitled “PCSK9 Inhibitor Access Barriers: Issues ...
(Date:3/22/2017)... ... 2017 , ... Soriant recognizes that identifying savings opportunities can ... facilities across the country are always forced to focus on costs and budgets. ... country, an efficient and quick way to estimate savings potential within specific support ...
(Date:3/22/2017)... ... March 22, 2017 , ... In recognition ... print media enterprise focused on cancer patients, cancer centers and advocacy groups, and ... 12-part educational video series, “No Ifs, Ands, or Butts,” that focuses on Colorectal ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017 Under the ... pharmaceutical packaging market size increased year by year ... 2017 to 2021, the market size will maintain ... expected to outnumber RMB140 billion in 2021, thanks ... rapid development of biological agents and supporting policies. ...
(Date:3/22/2017)... PRINCETON, N.J. , March 22, 2017 ... systems averted 77,342 cases of patient harm and saved ... thanks to their participation in a national quality improvement ... of progress under Partnership for Patients-New Jersey, part of ... and Human Services. HHS selected the New Jersey Hospital ...
(Date:3/22/2017)... 2017 Research and Markets has announced ... Market & Clinical Pipeline Insight 2022" drug pipelines to ... ... Pipeline Insight 2022 report gives comprehensive insight on clinical and ... check point inhibitors as main streamline drugs in the immunotherapy ...
Breaking Medicine Technology: